Suchergebnisse - "Meyer-Rath, Gesine"

PubPharm (4)

1

The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants

enthalten in: AIDS (London, England) | 2024

von Johnson, L. | Myer, L. | Jamieson, L. | +3

2

What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations

enthalten in: Journal of the International AIDS Society | 2023

von Meyer-Rath, G. | Jamieson, L. | Pillay, Y.

3

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa : a modelling study

enthalten in: The lancet. HIV | 2023

von Smith, J. | Bansi-Matharu, L. | Cambiano, V. | +35

CommentIn: Lancet HIV. 2023 Apr;10(4):e213-e215. - PMID 36642088

4

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials : a modelled economic evaluation and threshold analysis

enthalten in: The lancet. HIV | 2022

von Jamieson, L. | Johnson, L. | Nichols, B. | +4

CommentIn: Lancet HIV. 2022 Dec;9(12):e814-e815. - PMID 36356602

1
[1]